Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
This study suggests a greater impact than previously described in long-term outcomes of patients with GFAP astrocytopathy and reports concomitant tumor at presentation as a risk factor for relapse.
Authors
- Julian Theuriet (ORCID: https://orcid.org/0000-0002-5694-3759)
- Maxime Bonjour (ORCID: https://orcid.org/0000-0003-2205-9655)
- Marie Bénaiteau
- Pierre Lardeux
- Géraldine Picard (ORCID: https://orcid.org/0000-0003-1282-267X)
- Florian Lamblin (ORCID: https://orcid.org/0009-0009-2965-4781)
- Pauline Dumez
- Marie Rafiq (ORCID: https://orcid.org/0000-0002-1501-9113)
- Jérôme Honnorat (ORCID: https://orcid.org/0000-0002-4721-5952)
- Romain Marignier (ORCID: https://orcid.org/0000-0002-5967-2800)
- Joaquín Arzalluz-Luque
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Centre Hospitalier Universitaire de La Réunion (RE)
- Hospital Universitario Virgen Macarena (ES)
- Hospices Civils de Lyon (FR)
- Observatoire Français de la Sclérose en Plaques (FR)
- Hôpital Pierre Wertheimer (FR)
- Peuplements végétaux et bioagresseurs en milieu tropical (RE)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1007/s00415-025-13159-0
- Citations
- 6
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.34
Funders
- Agence Nationale de la Recherche
- Hospices Civils de Lyon